1. A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma
   Dylan B. Ness et al, 2023, Cancer Medicine CrossRef
2. Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma
   Siwei Yang et al, 2024, Heliyon CrossRef